Jennifer Klemp on Measuring Survivorship Outcomes
Jennifer Klemp, PhD, MPH, discusses the importance of measuring outcomes in survivorship care for patients with cancer.
Jennifer Klemp on the Cost of Survivorship Visits
Dr. Jennifer Klemp discusses ways to reduce the costs of survivorship visits for survivors of cancer.
Jennifer Klemp on Talking to a Patient About Genetics and Cancer
Jennifer Klemp, PhD, MPH, director, Breast Cancer Survivorship Center, The University of Kansas Cancer Center, discusses how to talk to a patient about genetics and cancer risk.
Durvalumab Garners Similar OS, Albeit Varied PFS, Outcomes in EGFR+ and EGFR-Wildtype NSCLC Subgroups
Quizartinib Extends Overall Survival Across Multiple Subgroups in FLT3-ITD+ AML
Repotrectinib Showcases Early Intracranial Responses in Select ROS1+ NSCLC
Osimertinib May Be More Effective in Frontline EGFR+ NSCLC When Combined With Chemo
2 Clarke Drive Cranbury, NJ 08512